Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trial
Xinrong Zhang(Tianjin Medical University), Vincent Wai‐Sun Wong(Chinese University of Hong Kong), Jimmy Che‐To Lai(Chinese University of Hong Kong), Lilian Yan Liang(Chinese University of Hong Kong), Alice P.S. Kong(Chinese University of Hong Kong), Wah‐Kheong Chan(University of Malaya), Grace Lai‐Hung Wong(Chinese University of Hong Kong), Lee‐Ling Lim(Chinese University of Hong Kong), Guanlin Li(Chinese University of Hong Kong), Huapeng Lin(Chinese University of Hong Kong), Wei-Xuan Leow(University of Malaya), Luqman Ibrahim(University of Malaya), Henry Lik‐Yuen Chan(Chinese University of Hong Kong), Angel Mei–Ling Chim(Chinese University of Hong Kong), Terry Cheuk‐Fung Yip(Chinese University of Hong Kong)
Cited by 47
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
|Proceedings of the National Academy of Sciences|2015|755